Catalyst
          Slingshot members are tracking this event:
          
        PDUFA Date Expected in July 2017 for Puma Bio's (PBYI) Neratinib in Extended Adjuvant Treatment of Patients with Early-Stage HER2+ Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance 
        
  | 
      Impact on Stocks
         | 
    ||||
|---|---|---|---|---|---|---|
| PBYI | 
             | 
          
  | 
          ||||
Slingshot Insights Explained
          
            Catalyst Date
          
            
                Occurred on: 
    Jul 17, 2017
 
        Occurred Source: 
         http://www.pumabiotechnology.com/pr20170717.html 
 
          
          
    Related Projects 
      
  
  - 
          
Don’t see a project related to the catalyst you care about?
 
            Related Keywords
            
    Pdufa Date, Neratinib, Extended Adjuvant Treatment, Early-stage Her2+, Breast Cancer